Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5415)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 24, 2023 (publication date) through Jan 29, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pathophysiology
ISSN
2150-5330
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Murphy CK, O’Donnell MM, Hegarty JW, Schulz S, Hill C, Ross RP, Rea MC, Farquhar R, Chesnel L. Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against Clostridioides difficile infection challenge in vivo. World J Gastrointest Pathophysiol 2023; 14(4): 71-85 [PMID: 37727283 DOI: 10.4291/wjgp.v14.i4.71] |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v14/i4/71.htm |
| Number | Citing Articles |
| 1 |
Sophie Irwin, Andrea Chupina Estrada, Becca Nelson, Ashlen Bullock, Berkeley Limketkai, Wendy Ho, Susan Acton, Laurent Chesnel, Hon Wai Koon. ADS024, a single-strain live biotherapeutic product of Bacillus velezensis alleviates dextran sulfate-mediated colitis in mice, protects human colonic epithelial cells against apoptosis, and maintains epithelial barrier function. Frontiers in Microbiology 2024; 14 doi: 10.3389/fmicb.2023.1284083
|
| 2 |
Ivan Sugrue, R. Paul Ross, Colin Hill. Bacteriocin diversity, function, discovery and application as antimicrobials. Nature Reviews Microbiology 2024; 22(9): 556 doi: 10.1038/s41579-024-01045-x
|
| 3 |
Susan Acton, Michelle M. O’Donnell, Kalaichitra Periyasamy, Bharat Dixit, Haifeng Eishingdrelo, Colin Hill, R. Paul Ross, Laurent Chesnel. LPA3 agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease models. Brain, Behavior, and Immunity 2024; 121: 384 doi: 10.1016/j.bbi.2024.08.024
|